Lufthansa Cargo clears the new CSafe RAP Temperature-Controlled Container for departure

(PresseBox) ( Frankfurt/Dayton, )
CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is pleased to announce that Lufthansa Cargo is the latest airline to qualify and approve the CSafe RAP for flight

Lufthansa Cargo has approved the CSafe RAP for transport on their extensive network of airlines, serving over 300 destinations in more than 100 countries worldwide. The strong performance and unmatched thermal protection of the CSafe RAP is quickly attracting attention and gaining approval to fly on airlines around the world.

Thorsten Braun, Senior Director of Industry Development & Product Management says, “To me it represents a typical win-win situation. With the addition of the CSafe RAP we are further expanding our portfolio of active cool containers, which is second to none, while intensifying our existing relationship with CSafe. In combination with our extensive global network, we are offering one of the leading cool containers to our customers!”

Jeff Pepperworth, Chief Executive Officer for CSafe Global states, “We’re excited to add Lufthansa Cargo to our expansive network of airline partners approved to fly the CSafe RAP. We are honored to deepen our relationship with Lufthansa Cargo and strengthen our promise to protect what matters most to pharmaceutical customers so that patients can receive what matters most to them.”

The CSafe RAP represents CSafe’s dedication to quality, ensuring the temperature integrity and safe delivery of temperature-sensitive, life-enhancing products across the globe. By utilizing CSafe’s proprietary ThermoCor® VIP insulation together with an innovative cooling and heating system, the CSafe RAP precisely maintains a defined payload temperature set-point throughout product transport, even in the most extreme ambient conditions (-30°C to +54°C). This is the broadest operating range in the industry.

Customers seeking more information about any of the CSafe active temperature-controlled containers or their leasing options should visit

CSafe Global

CSafe Global manufactures and offers a full range of active and passive cold-chain packaging solutions to address the needs of pharmaceutical and life science companies around the world. The company markets the CSafe® brand of innovative active container systems, as well as the AcuTemp® and Kalibox® brands of passive packaging solutions and hand-held mobile carriers. CSafe Global is also the exclusive manufacturer and provider of the superior vacuum insulation - ThermoCor® VIP. CSafe Global's active system product range includes the industry leading CSafe® RKN and newly released CSafe® RAP, the only high-performing temperature-controlled containers of their kind with approvals to fly on either upper or lower decks of aircraft. The CSafe® RKN and CSafe® RAP both utilize heating and compressor-driven cooling technologies to eliminate the payload risks associated with extreme ambient temperature conditions and long-duration shipments. CSafe's AcuTemp® brand has provided temperature management solutions since its founding more than 30 years ago. The AcuTemp® courier is a simple-to-use, reusable temperature management system with multiple sizes, temperature ranges, and durations designed to protect vital shipments during last mile delivery. The AcuTemp® \passive packaging range leverages ThermoCor® VIP and includes parcel solutions for 2-8°C, CRT, and frozen shipments with temperature hold times up to 240 hours. The Kalibox® passive system portfolio utilizes polyurethane technology and encompasses a full range of innovative temperature-controlled solutions, including insulated passive pallet shippers (PPS).
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to